DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial.

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 6|浏览1
暂无评分
关键词
advanced pleural mesothelioma—a,durvalumab,chemotherapy,dream3r,first-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要